SecSonar.com

Privia Health Group, Inc. (PRVA)

Privia Health Group, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Privia Health Group, Inc. (PRVA) is a Medical - Healthcare Information Services company based in US with a market capitalization of $2.7B. Revenue grew 22.3% year-over-year and the company generated $162.2M in free cash flow. This page tracks PRVA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.14K employees · IPO Apr 28, 2021

Valuation

Valuation & price

$22.95 · as of May 17, 2026 · -16.1% vs 52w high

129.1

P/E ratio

Latest-FY diluted EPS

3.70

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$27.36$23.41$19.47Jul 25Dec 25Jul 26Jul 7, 25$21.35Jul 9, 25$21.20Jul 11, 25$20.47Jul 15, 25$20.64Jul 17, 25$20.71Jul 21, 25$20.16Jul 23, 25$20.30Jul 25, 25$19.70Jul 29, 25$19.48Jul 31, 25$19.52Aug 4, 25$19.47Aug 6, 25$19.78Aug 11, 25$20.31Aug 13, 25$21.02Aug 15, 25$21.27Aug 19, 25$21.21Aug 21, 25$21.33Aug 25, 25$21.40Aug 27, 25$21.75Aug 29, 25$23.04Sep 3, 25$23.17Sep 5, 25$23.28Sep 9, 25$23.43Sep 11, 25$22.91Sep 16, 25$22.32Sep 18, 25$22.61Sep 22, 25$22.90Sep 24, 25$23.34Sep 26, 25$23.96Sep 30, 25$24.90Oct 2, 25$24.46Oct 6, 25$24.13Oct 8, 25$24.53Oct 10, 25$24.08Oct 14, 25$24.81Oct 16, 25$25.53Oct 21, 25$26.01Oct 23, 25$25.88Oct 27, 25$25.73Oct 29, 25$25.60Oct 31, 25$24.30Nov 4, 25$24.69Nov 6, 25$23.98Nov 10, 25$23.41Nov 12, 25$24.22Nov 14, 25$23.45Nov 18, 25$23.13Nov 20, 25$22.55Nov 25, 25$24.56Nov 28, 25$24.37Dec 2, 25$24.00Dec 4, 25$24.00Dec 8, 25$23.63Dec 10, 25$24.18Dec 12, 25$24.91Dec 16, 25$23.81Dec 18, 25$23.94Dec 22, 25$24.02Dec 24, 25$23.69Dec 29, 25$23.86Jan 2, 26$23.46Jan 6, 26$24.42Jan 8, 26$23.15Jan 12, 26$23.42Jan 14, 26$22.85Jan 16, 26$23.32Jan 21, 26$23.60Jan 23, 26$23.94Jan 27, 26$22.86Jan 29, 26$22.87Feb 2, 26$23.41Feb 4, 26$22.01Feb 9, 26$21.63Feb 11, 26$21.60Feb 13, 26$22.39Feb 18, 26$21.78Feb 20, 26$21.99Feb 24, 26$21.53Feb 26, 26$24.91Mar 2, 26$24.04Mar 4, 26$24.30Mar 6, 26$23.27Mar 10, 26$22.47Mar 12, 26$21.73Mar 17, 26$22.10Mar 19, 26$21.77Mar 23, 26$21.52Mar 25, 26$20.54Mar 27, 26$20.02Mar 31, 26$20.57Apr 2, 26$21.21Apr 7, 26$22.38Apr 9, 26$22.71Apr 13, 26$23.01Apr 15, 26$23.44Apr 17, 26$24.02Apr 22, 26$23.86Apr 24, 26$23.84Apr 28, 26$24.84Apr 30, 26$24.85May 4, 26$24.24May 6, 26$23.99May 8, 26$23.06May 12, 26$23.01May 14, 26$23.24May 18, 26$23.69May 20, 26$23.18May 22, 26$22.79May 28, 26$21.59Jun 1, 26$21.31Jun 3, 26$20.66Jun 5, 26$21.63Jun 9, 26$22.17Jun 11, 26$23.36Jun 15, 26$23.02Jun 17, 26$23.41Jun 22, 26$23.49Jun 24, 26$24.51Jun 26, 26$25.57Jul 2, 26$27.36
$18.8652-week range$27.36
Loading valuation history…

Fundamentals

Key fundamentals

$2.7B

Market cap

22.3%

Revenue growth (YoY)

9.9%

Gross margin

$162.2M

Free cash flow (USD)

-$470.2M

Net debt

Net cash position

2.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$657.6MFY 2019$786.4MFY 2020$817.1MFY 2021$966.2MFY 2022$1.4BFY 2023$1.7BFY 2024$1.7BFY 2025$2.1B
$657.6M$2.1B

Free cash flow by year

2018 → 2025

FY 2018$5.0MFY 2019$18.6MFY 2020$38.5MFY 2021$54.5MFY 2022$47.1MFY 2023$80.7MFY 2024$104.3MFY 2025$162.2M
$5M$162.2M

Gross margin by year

2021 → 2025

FY 20216.6%FY 20229.9%FY 20239.7%FY 202410.2%FY 20259.9%
6.6%9.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $433K · 10b5-1 PlanMountcastle David · EVP & Chief Financial Officer · $433KJun 30, 2026Filing
  • Insider sellInsider Sell $3.8M · 10b5-1 PlanMorris Matthew Shawn · Director · $3.8MJun 30, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 22, 2026Filing
  • Insider sellInsider Sell $77KMountcastle David · EVP & Chief Financial Officer · $76.5KMay 13, 2026Filing
  • Insider sellInsider Sell $2.7M · 10b5-1 PlanMehrotra Parth · Director, Chief Executive Officer · $2.7MMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • Insider sellInsider Sell $453K · 10b5-1 PlanMorris Matthew Shawn · Director · $452.6KMay 5, 2026Filing
  • Insider sellInsider Sell $210K · 10b5-1 PlanMountcastle David · EVP & Chief Financial Officer · $209.8KMay 5, 2026Filing
  • Insider sellInsider Sell $116KMountcastle David · EVP & Chief Financial Officer · $116.1KApr 6, 2026Filing

Questions

Frequently asked questions

What is Privia Health Group, Inc.'s market cap?

Privia Health Group, Inc. (PRVA) has a market capitalization of $2.7B.

What is PRVA's P/E ratio?

PRVA trades at a price-to-earnings ratio of 129.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PRVA's price-to-book (P/B) ratio?

PRVA trades at 3.70 times book value per share.

Are insiders buying PRVA stock?

SEC Form 4 filings show no open-market insider buys at Privia Health Group, Inc. in the last 90 days (7 sells).

Same arena

Related companies in Medical - Healthcare Information Services

HTFL

Heartflow, Inc. Common Stock

$2.7B

PGNY

Progyny, Inc.

$2B

OMCL

Omnicell, Inc.

$2B

TXG

10x Genomics, Inc.

$3.6B

WGS

GeneDx Holdings Corp.

$1.5B

DOCS

Doximity, Inc.

$4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.